B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8 + tumor-infiltrating lymphocytes
2021; American Association for the Advancement of Science; Volume: 7; Issue: 3 Linguagem: Inglês
10.1126/sciadv.aax3160
ISSN2375-2548
AutoresGihoon You, Yangsoon Lee, Yeon‐Woo Kang, Han Wook Park, Kyeongsu Park, Hyekang Kim, Young‐Min Kim, Sora Kim, Jihae Kim, Dain Moon, Hyejin Chung, Wonjun Son, Ui-jung Jung, Eun Young Park, Shinai Lee, Yong-Gyu Son, Jaehyun Eom, Jonghwa Won, Yunji Park, Jaeho Jung, Seung‐Woo Lee,
Tópico(s)Immunotherapy and Immune Responses
ResumoTumor-targeted T cell costimulatory antibody augments antitumor immunity by enhancing tumor-killing T cells within the tumor.
Referência(s)